Mass Tort Lawyers
Our Mass Tort lawyers are willing to fight big drug companies and represent individuals who have been harmed by the pharmaceutical companies and by medical device companies. We are currently litigating cases involving DePuy ASR XL Acetabular Hip System, DePuy Pinnacle Hip System, Saint Gobain Advanced Ceramic Coated Femoral Head Hip Implant Components, Fosamax®, Chantix, Zimmer NexGen Knee System, Pradaxa and Imprelis. We are investigating cases involving Zimmer Durom Hip System, Wright Profemur Hip System, Avandia, Meridia, Topamax®, Bard Inferior Vena Cava Blood (IVC) Filters, Digitek, Fentanyl Patches and Zoloft.
Our proven, experienced trial lawyers have earned a national reputation. Read more. Some of the matters in which we have been involved with represent precedent-setting changes in the law and accomplishments on behalf of our clients. These include:
Articles and News
Consumer Alert: Fosamax May Cause Osteonecrosis ("Jaw Death")
Fosamax is a medicine in the bisphosphonates family that is prescribed widely to prevent bone loss or the decrease of bone density. There have been reports that persons taking Fosamax have developed a severe problem in which bone in their jaws dies.
Consumer Alert: Chantix Patients Report Dangerous Side-Effects
Chantix, chemical name varenicline, is a drug sold by Pfizer to patients who wish to quit smoking. The drug works by affecting dopamine, nicotinic and other chemical transmitters in the brain.
Consumer Alert Update: Zimmer NexGen Flex Knee Implants Lititation
The Zimmer NexGen Flex knee replacement system, manufactured by Zimmer Inc., is marketed as a line of "high-flex" knee implants designed to give knee replacement recipients greater range of motion. However, studies have shown that these high-flex implants can lead to pain, loosening, and instability in the knee, requiring removal and replacement of the implants.
Attorney Kate Jaycox Selected to Serve on American Association for Justice Board of Governors
Robins, Kaplan, Miller & Ciresi L.L.P. is pleased to announce that Kate Jaycox has been selected to serve on the American Association for Justice (AAJ) Board of Governors.
Tara Sutton to Co-Chair Food, Drug and Medical Device Litigation Conference
The conference, which takes place in Minneapolis, is scheduled for April 23-24, 2012.
Consumer Alert: Pradaxa Blood Thinner Linked To Heart Attacks
A new study released January 9, 2012 found that Pradaxa carries an increased risk of heart attack compared with other anti-coagulant medications.[
Firm's Mass Tort Practice Receives Tier 1 Rating
For a second year in a row, the Mass Tort group at Robins, Kaplan, Miller & Ciresi L.L.P. has been recognized as a top tier litigation practice by U.S. News Media Group and Best Lawyers.**
Consumer Alert Update: Imprelis® MDL Created and Information on Imprelis® Claims Program
The DuPont chemical company's Imprelis® herbicide has been linked to the significant damage and death of desirable vegetation including trees, shrubs, and ornamental plants. On August 10, the Environmental Protection Agency (EPA) ordered DuPont to halt the sale, use, and distribution of the chemical.
Consumer Alert: Imprelis Herbicide Class Action
On August 5, 2011, Robins, Kaplan, Miller, & Ciresi L.L.P. filed a Minnesota class action lawsuit against the DuPont chemical company over its herbicide ImprelisTM.
Consumer Alert: JPML Separates Minn. Plaintiff's ASR and Pinnacle Hip Replacement Claims
The Judicial Panel on Multidistrict Litigation has divided DePuy ASR and Pinnacle hip implant claims asserted by a Minnesota woman in a single federal lawsuit and conditionally assigned them to pending MDLs in Texas and Ohio.
Consumer Alert Update: DePuy ASR Hip Implant Recall
Partner Tara Sutton has been appointed to Co-Chair the Plaintiffs' Law and Briefing Committee in the DePuy ASR MDL. Partner Vincent J. Moccio has been appointed to the DePuy MDL Discovery Committee.
Consumer Alert Update: DePuy Pinnacle Hip Implants
On May 16th, 2011, the Judicial Panel on MultiDistrict Litigation will consider a Petition to create an MDL devoted to litigation concerning the DePuy Pinnacle.
MDL No. 2244 Established for DePuy Pinnacle Hip Implant Cases Claiming Premature Failure
DePuy Orthopaedics, Inc. is facing public scrutiny regarding the reportedly premature loosening and failure of its Pinnacle hip prostheses.
Consumer Alert: FDA Warns Prescription Drug TOPAMAX®. Causes Birth Defects
Tara D. Sutton Apppointed to Plaintiff's Law and Motions Commitee in dePuy ASR MDL
On January 26, 2011, U.S. District Court Judge David A. Katz appointed partner Tara D. Sutton to the Plaintiffs' Law and Motions Committee in the DePuy ASR Multi-District Litigation.
Consumer Alert: Johnson & Johnson Recalls DePuy ASR XL Acetabular Hip System
On August 26, 2010, the DePuy Orthopaedics unit of Johnson & Johnson announced that it was recalling two hip replacement products: the ASR XL Acetabular System and the ASR Hip Resurfacing System.
Consumer Alert: Abbott Laboratories Withdraws Its Obesity Drug Meridia
The drug maker Abbott Laboratories has agreed to take its weight loss and obesity drug Meridia (substance name sibutramine) off the market, the U.S. Food and Drug Administration ("FDA") announced Friday, October 8.
FDA Reports Dangerous Risks of Adverse Events with Bard Inferior Vena Cava Blood (IVC) Filters
Every year hundreds of thousands of Americans suffer from venous thromboembolism (VTE), deep-vein thrombosis (“DVTs”) and/or pulmonary embolism (“PEs”), commonly referred to as “blood clots.” For certain patients, an intervenous vena cava filter (“ICV filter”) is implanted in the vein leading to a patient’s heart in an effort to prevent these blood clots.
Avandia Consumer Alert: More Negative Data Emerges as FDA Advisory Board Recommends Stronger Warnings
Avandia is a drug used to control blood sugar for Type 2 diabetics, but has been associated with multiple safety issues, including heart attacks, congestive heart failure, strokes and bone fractures.
Yaz, Yasmin and Ocella's Dangerous Side Effects
Birth control pills Yaz, Yasmin and the generic Ocella have a unique ingredient called drospirenone, a synthetic progestin, which is not found in other birth control pills. Drospirenone has been associated with a number of severe side effects.
Toyota's Sudden Acceleration Recall
Following a recall of over 8 million Toyota vehicles, a safety researcher has reported that he found 19 deaths and 341 injuries resulting from 815 separate crashes involving the sudden acceleration of Toyotas.
Out of the Frye Pan and Into the Fire: Handling Frye-Mack Challenges in Your Products Liability Case
Hardly a case goes to trial these days without an expert witness. Expert witnesses often make or break a case, particularly in a complex products liability case. But trial lawyers often have a difficult time getting that testimony admitted.
Update: Increased Concern over Mounting Numbers of Reported Deaths and Serious Injuries Prompt the FDA to Order Testing of Medical Devices Containing Heparin
The FDA has found an association between a contaminant in the blood-thinning drug heparin and severe adverse reactions which are being reported.
Consumer Alert: Digitek Heart Failure Medications Recalled - A Serious Risk of Injury or Death to the Patient
On April 25, 2008 Actavis Totowa LLC (formerly known as Amide Pharmaceutical, Inc.) announced the Class I nationwide recall of all strengths of oral Digitek tablets, which is a brand name for digoxin tablets, USP 0.125 mg and 0.25 mg.
Victims' Fund Won't End I-35W Bridge Litigation
The recently passed bill creating an I-35W bridge victims' compensation fund should resolve the question of the state's potential liability to victims of the bridge collapse, but won't end bridge-related litigation against third parties.
Fentanyl Patches Recalled
On February 12, 2008, PriCara announced that patches containing the prescription painkiller “fentanyl” are being recalled.
New Study Shows Women Using the Ortho Evra Birth-Control Patch Double Risk of Blood Clots Compared With Those Taking Birth Control Pill
Women using the Ortho Evra birth-control patch have twice the risk of developing blood clots than those who take the pill according to a new study funded by Ortho Women’s Health & Urology, the manufacturer of the patch.
Four Awarded $1.86M in Derailment Damages
Minneapolis Canadian Pacific Railway must pay four people nearly $1.86 million for injuries they suffered as a result of a 2002 derailment near Minot, N.D., that spilled a cloud of anhydrous ammonia, a jury here decided Wednesday.
Latest News on VIOXX Recall
We are continuing to review claims related to the pain reliever VIOXX, which was withdrawn from the market on September 30, 2004 by Merck & Co., Inc. after a long-term clinical trial demonstrated an increased risk of heart attacks and strokes.
Litigation Practices > Mass Tort Lawyers